FDA Generic Drug Review Times Accelerate; ANDA Approvals Faster

FDA generic drugs program monthly and quarterly activity reports released April 17 showed ANDA average approval time dropping from 35.93 months in Q1 to 32.82 months in Q2; median fell from 25.65 to 20.29 months. April saw 17 first-cycle approvals.